搜索临床试验以:SHR-A2009
总计1911个结果
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Chinese PLA General Hospital招聘中
-
Jiangsu HengRui Medicine Co., Ltd.尚未招聘HER2 阳性复发性或转移性乳腺癌
-
Shanghai Zhongshan HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
University of ChicagoNational Institute on Aging (NIA); University of North Carolina, Chapel Hill尚未招聘
-
Clarity Pharmaceuticals Ltd完全的
-
University Hospital Inselspital, BerneUniversity of Bern; CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et...完全的
-
Stanford UniversityGE Healthcare招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University完全的
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Jiangxi Provincial Cancer Hospital; Shenzhen People's Hospital 和其他合作者招聘中
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Fudan University招聘中乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤 | HER2阳性乳腺癌 | 局部晚期乳腺癌 | HER2 阴性乳腺癌 | 激素受体阳性肿瘤 | 激素受体阴性肿瘤 | 早期乳腺癌 | 三阴性乳腺癌 (TNBC)中国
-
Jon SnaedalKarolinska University Hospital; Ullevaal University Hospital; Zealand University Hospital; Rigshospitalet... 和其他合作者未知
-
Weill Medical College of Cornell UniversityNew York State Department of Health完全的
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)完全的
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research Program完全的
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)终止
-
Seres Therapeutics, Inc.完全的
-
Icahn School of Medicine at Mount SinaiNYC Health + Hospitals完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中先前接受过曲妥珠单抗和紫杉烷治疗的 HER2 阳性、不可切除和/或转移性乳腺癌受试者中国
-
National Cancer Institute (NCI)主动,不招人宫颈癌 | 肛门癌 | 口咽癌 | 外阴癌、阴道癌、阴茎癌、直肠癌 | HPV 阳性癌症美国
-
University of North Carolina, Chapel HillMayo Clinic; National Library of Medicine (NLM); University of Pittsburgh Medical Center; MedStar...招聘中